Combined Shareholders’ Meeting of 31 May 2023

This article or press release has no online content. Please download the associated documents for more information.

Associated Documents

2022-Universal-registration-document-Ipsen.pdf
Report-of-the-Board-of-Directors-on-the-draft-resolutions.pdf
Preliminary-notice-to-the-Meeting-published-at-the-BALO-on-21-April-2023-French-version.pdf
Preliminary-notice-to-the-Meeting-published-at-the-BALO-on-21-April-2023-Translation-for-information.pdf

Applications now open for the 2023 Golden Ticket Competition

Offering support to those impacted in Turkey & Syria

Ipsen delivers FY and Q4 2022 results – A word from CEO David Loew

J.P. Morgan Conference 2023: Ipsen shares strategy success

© Ipsen Pharma, 65 Quai Georges Gorse, 92100 Boulogne-Billancourt, France. All rights reserved - 2023